Meeting Highlights from AACE 26th Annual Scientific & Clinical Congress

May 3-7, 2017
Austin Convention Center
JW Marriott Austin
Austin, TX

Highlights of key sessions presented at the 2017 American Association of Clinical Endocrinologists (AACE) annual meeting offer practitioners the opportunity to learn about advances in clinical care and new applications in device technology to inform patient care and enhance your clinical practice.

EndocrineWeb selected five sessions featuring clinical discourse that the editorial team deemed both newsworthy and of clinical relevance, as follows:

Nuanced Frailty of the Obese Aging Patient

A panel of specialists in gerontology recognized the added burden of frailty that comes with sarcopenia. The wasting of lean muscle mass assures these individuals a loss of independence and reduced quality of life.  These concerns in the aging US population become greater with each additional decade of life beyond age 60 years old. 

John E. Morley, MBBCh, director of geriatric medicine at St. Louis University School of Medicine in Missouri, took a surprising perspective in drawing attention to the challenges of a sedentary patient population who is also obese, not what one would expect to discuss in a session on sarcopenia. Yet, he made a strong case for screening all patients with type 2 diabetes (T2D) over 50 years of age for skeletal muscle changes. Any noted declines in muscle strength such as gait speed, or decreased ability to perform activities of daily living might suggest a loss of lean muscle mass, and/or functional capacity. These patients should be referred for physical therapy or prescribed a resistance exerice program to reverse their risk of early mortality 

More Data Promises More Informed Clinical Insight and Better Self-Care 

A series of diabetes experts discussed ways that diabetes management may be expected to improve given the array of technological innovations on the horizon. They were also quick to point out the challenges that endocrinologists and primary care physicians should brace for in having to adjust to the onslaught of data to be obtained, interpreted, stored, and responded to in adjusting each patient's medical care plan. 

Irl B. Hirsch, MD, professor of medicine at the University of Washington in Seattle, indicated that healthcare providers should anticipate a sea change in diabetes management—switching our focus from monitoring changes in hemoglobin A1c (HbA1c) o that of glucose levels.  As patients adopt glucose monitoring devices, the goal will become one of teaching patents to remain in-range, rather than aiming for a less accurate HbA1c level.

Time for a Multidisciplinary Approach to Hypoparathyroid Disease




Last updated on
First Article From This Meeting:
Aging Individuals Require Nuanced Endocrine Treatment
close X